David R. Bundle
Patents
23 Bundle, D.R., Kitov, P.I. Multivalent
Heterobifunctional Polymer Therapeutics and Methods of Their Use.
US Provisional Patent application filed: March 23rd, 2007.
22 Bundle, D.R., Kitov, P.I. Grant, G. Lipinski,
T. Dziadek, S. Methods and compositions for pharmacologically controlled
targeted immunotherapy. International and US Patent application Serial
No. 11/602,493 filed: November 21, 2006.
21 Bundle, D.R Wu, X., Rennie, R. Lipinski,
T. Synthetic anti-Candida albicans oligosaccharide based vaccines.
US Patent application filed: March 14th, 2006.
20 Bundle, D.R., Kitov, P.I. Grant G. Methods
and compositions for pharmacologically controlled targeted immunotherapy.
US Provisional Patent application filed: November 21st, 2005.
19 Bundle, D.R Wu, X., Rennie, R. Synthetic
anti-Candida albicans oligosaccharide based vaccines. US Provisional
Patent application filed: April 29th, 2005. 18 Bundle, D.R Wu, X.. Synthesis of glycoconjugate
vaccines against Candida albicans using the novel linker methodology.
US Provisional
Patent application filed: March 14th, 2005.
17 Bundle, D.R., Kitov,
P., Ng, K. K-S., Ho, J.G.S. Multivalent Inhibitors of Serum Amyloid
P Component. US patent application filed:
May 12th, 2004.
16 Bundle, D.R., Kitov, P. Glycerol Cyclic
Pyruvate Derivatives. US Provisional patent application filed: May
12th,
2003
15 Bundle, D.R., Ling, C-C. and Zhang, P.
Synthetic methods for the large scale production from glucose of
analogs of sphingosine,
azidosphingosine, ceramides, lactosyl ceramides, and glycosyl phytosphingosine.
International patent application filed: June 1st, 2003.
14 Bundle, D.R., Nitz, M. and Cutler, J.E.
Synthetic anti-Candida albicans oligosaccharide based vaccines. International
patent application,
filed April 25th, 2003.
13 Bundle, D.R., Ling, C-C. and Zhang, P. Synthetic methods for
the large scale production from glucose of analogs of sphingosine,
azidosphingosine, ceramides, lactosyl ceramides, and glycosyl
phytosphingosine. US Provisional patent application filed: May 31st,
2002.
12 Bundle, D.R., Nitz, M. and Cutler, J.E. Synthetic anti-Candida
albicans oligosaccharide based vaccines. US Provisional patent
application, filed April 26th, 2002.
11 Srivastava, O.P., Srivastava, G., Du, M., Hindsgaul, O., Bundle,
D.R. and Liav, Avraham. Synthesis of 4,7-dialkyl chromogenic glycosides
of N-acetylneuraminc acids. US 6, 303, 764.
10 Bundle, D.R., Kitov, P, Read, R.J., Ling, H. and Armstrong, G.Treatment
of Bacterial Infections. US 6,310,043. October 30th, 2001.
9 Lennox, R.B., Hodges, R.S., Irvin, R.T., Armstrong, G.D., Kitov,
P.I, Railton, C. Biosensor Device and Method. U.S. 5,955,379, September
21, 1999.
8 Bundle, D.R., Kitov, P.I., Read, R.J., Ling, H., Armstrong, G.D.Treatment
of Bacterial Dysentery. U.S. 5962423. October 5th, 1999.
7 Srivastava, O.P., Srivastava, G., Szweda, R., Bundle, D.R., Hindsgaul,
O., Hanna, H.R., Holme, K., Barresi, F.W. and Du, M. Oligosaccharide
Glycosides having Mammalian Immunosuppresive and Tolerogenic Properties.
U.S. 5,784,411. February 23, 1999.
6 Cherwonogrodzky, J.W., Duncan, R., Nielsen, K., Wright, P., Bundle,
D.R., and Perry, M.B. Immunoassays for Discriminating between Brucellosis
Infections and Vaccinations. Canadian Patent 1,336,576. August 8,
1995.
5 Cherwonogrodzky, J.W., Duncan, R., Nielsen, K., Wright, P., Bundle,
D.R., and Perry, M.B. Immunoassays for Discriminating between Brucellosis
Infections and Vaccinations. United States Patent 5,006,463. April
9, 1991.
4 Bundle, D.R., Perry, M.B., Cherwonogrodzky, J.W., Duncan, J.R.,
and Caroff, M.G. Antigenic polysaccharide specific to Brucella
abortus and Yersinia enterocolitica serotype O:9. United
States Patent No. 4,831,126, May 16, 1989.
3 Bundle, D.R., Perry, M., Cherwonogrodzky, J., Duncan, R., and
Caroff, M.Identification of Brucella abortus and Brucellosis
infection. Canadian Patent No. 1,212,051, Sept. 30, 1986.
2 Lemieux, R.U., Bundle, D.R., and Baker, D.A. Artificial oligosaccharide
antigenic determinants. United States Patent 4,238,473.
1 Lemieux, R.U., Bundle, D.R., and Baker, D.A. Synthetic polysaccharide
antigenic determinant for human blood groups. American, British,
Canadian, Dutch, French and West German patents pending. U.S. Patent
4,137,401 granted January 30, 1979.
 Back
to People
|
|
 |
|
Profile
Publications
Reviews and Book
Chapters
Patents
|
